TheraPEAK® X-VIVO® 15, Serum-free Hematopoietic Cell Medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1 L
TheraPEAK® X-VIVO® 15 Serum-free Hematopoietic Cell Medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1L bag
TheraPEAK® X-VIVO® 15 Serum-free Hematopoietic Cell Medium, with recombinant transferrin, with L-Glutamine, without gentamicin and phenol red, xenofree, 1L bag
TheraPEAK® X-VIVO® 15 Serum-free Hematopoietic Cell Medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 5L bag
TheraPEAK® X-VIVO® 15 Serum-free Hematopoietic Cell Medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 5L bag
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC), from a single donor, in EGMTM-2 containing ≥ 500,000 cells
Cryopreserved ampule of Adult Human Dermal Microvascular Endothelial Cells (HMVEC-d Ad) containing ≥ 500,000 cells
CDMTM Chondrocyte Differentiation SingleQuots® Kit
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC), from pooled donors, in EGMTM-2 and containing ≥ 500,000 cells
-
Terms and ConditionsCD34+ cells BOGO
-
Mitosis of CD34+ cells with Nanolive's 3D Cell ExplorerHuman cord blood CD34+ stem/progenitor cells were cultured in X-VIVO™ 15 serum-free hematopoietic cell medium, supplemented with recombinant human thrombopoietin (25ng/mL), Rlt3 ligand (25ng/mL) and stem cell factor (13ng/mL). The culture was coated with fibronectin. Live cell imaging was performed with Nanolive’s 3D Cell Explorer for 15 hours (3 images/min during 15hours) and cell division was captured. One can distinguish characteristic steps of mitosis affirming that Nanolive’s technology was completely non-invasive. -
CD34+ Cells for Cell and Gene Therapy Process DevelopmentIn this interview Dr. Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade CD34+ cells for cell and gene therapy process development. Please register to read.
-
Human CD34+ Cells Technical information and instructions for use
-
Transfection Protocol for Human CD34+ Cells - HT Nucleofector™ DeviceInstructions of use for transfection of human CD34+ cells with the P3 Primary Cell HT-Nucleofector™ Kit
-
Transfection Protocol for Human CD34+ Cells - 4D-Nucleofector™ DeviceInstructions of use for transfection of human CD34+ cells with the P3 Primary Cell 4D-Nucleofector™ X Kit
-
Transfection Protocol for Human CD34+ Cells - 96-well Shuttle™ DeviceInstructions of use for transfection of human CD34+ cells with the P3 Primary Cell 96-well Nucleofector™ Kit
-
Transfection Protocol for Human CD34+ Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human CD34+ cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
Live-cell imaging of CD34+ cells with Nanolive’s 3D Cell ExplorerHuman cord blood CD34+ stem/progenitor cells were cultured in X-VIVO™ 15 serum-free hematopoietic cell medium, in the presence of recombinant human thrombopoietin (25ng/mL), Rlt3 ligand (25ng/mL) and stem cell factor (13ng/mL). The culture was coated with fibronectin. Live cell imaging was performed with Nanolive’s 3D Cell Explorer for 15 hours (3 images/min during 15hours) and cell migration was captured. -
Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic ResearchLonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf